High Quality 99% Purity HCG Raw Powder Chemical Intermediates Weight Loss Peptides
TDS 11 Inquiries
56832-34-9
Pharmaceutical Grade
99.9%
qingdao
China
0.05kg
2029-12-31
peptides
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionResearch & Reference Note
High Quality 99% Purity HCG Raw Powder Chemical Intermediates Weight Loss Peptides is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
BETA-HCG
Other Name:BETA-HCG;BETA-HCG INTACT;HCG;HCG BETA;CHORIONIC GONADOTROPHIN, BETA-, HUMAN INTACT;CHORIONIC GONADOTROPIN-BETA;CHORIONIC GONADOTROPIN, BETA-SUBUNIT;CHORIONIC GONADOTROPIN BETA-SUBUNIT HUMAN
CAS No.:56832-34-9
Categories:
Characteristics-
Appearance:
powder
Storage Conditions:−20°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptides
-
Location:
Room 1001, Unit 2, Building 30, Xing'an Community, Dongcheng Street, Ancheng Town, Pingyin District, Jinan City, Shandong Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2022
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted
United States
Hcg
10 PCS Feb 10, 2026
United States
High Quality HCG 99%
1 May 23, 2025
Italy
HCG 10000 iu
2 MT Dec 1, 2024
Italy
Hcg
200 MG Nov 23, 2024
United States
hcg and igf 1
10 MT Apr 25, 2026
Netherlands
Hcg raw powder
10 G Mar 25, 2026
United States
HCG
10 MG Dec 12, 2025
Canada
HCG
1 KG Aug 7, 2025
Australia
Hcg
200 MT Jun 30, 2026
Netherlands
HCG
5 Feb 26, 2026
Sweden
High Purity 10000iu/vial 5000iu HCG Hot Selling Peptide Tested HCG Powder CAS 56832-34-9
10 May 13, 2026 Post an enquiry for this product
Retatrutide—developed by pharmaceutical giant Eli Lilly and alternatively known as GGG Tri-agonist, GLP-1/GIP/glucagon tri-agonist, or LY3437943—is an injectable breakthrough poised for FDA approval, with significant potential to treat obesity and diabetes. While it shares similarities with established weight loss therapies like tirzepatide and semaglutide, retatrutide delivers enhanced efficacy. When paired with balanced nutrition, consistent physical activity, and healthy lifestyle adjustments, it not only amplifies weight loss results but also addresses obesity-related comorbidities such as diabetes and hypertension (high blood pressure).